Treatment of chronic idiopathic urticaria with levamisole: A multicentre, randomized, double-blind, controlled trial

Journal of International Medical Research

Volumn 37, Issue 4, 2009, Pages 1167-1172

  Zhang, Hongming ^a   Shan, C ^a   Hua, Z ^b   Zhao, P ^a   Zhang, H ^c  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

^c Xinghua Traditional Chinese Hospital   (China)

Author keywords

Chronic idiopathic urticaria; Efficacy rate; Levamisole; Levocetirizine; Therapeutic effect

Indexed keywords

LEVAMISOLE; LEVOCETIRIZINE; CETIRIZINE; HISTAMINE H1 RECEPTOR ANTAGONIST; IMMUNOLOGICAL ADJUVANT;

ADULT; ARTICLE; CHRONIC URTICARIA; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; CHRONIC DISEASE; DRUG COMBINATION; PATHOPHYSIOLOGY; PRURITUS; TREATMENT OUTCOME; URTICARIA;

ADJUVANTS, IMMUNOLOGIC; ADULT; CETIRIZINE; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; LEVAMISOLE; MALE; PRURITUS; TREATMENT OUTCOME; URTICARIA;

EID: 70350506550     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700422     Document Type: Article

References (11)

1. Greaves MW: Chronic idiopathic urticaria. Curr Opin Allergy Clin Immunol 2003; 3: 363-368.
2. Piconi S, Trabattoni D, Iemoli E, et al: Immune profiles of patients with chronic idiopathic urticaria. Int Arch Allergy Immunol 2002; 128: 59-66. (Pubitemid 34621667)
3. Ferrer M, Luquin E, Sanchez-Ibarrola A, et al: Secretion of cytokines, histamine and leukotrienes in chronic urticaria. Int Arch Allergy Immunol 2002; 129: 254-260. (Pubitemid 35370024)
4. + peripheral T lymphocytes in patients with chronic idiopathic urticaria. Acta Derm Venereol 2002; 82: 249-253.
5. Gennaro AR (ed): Remington: the Science and Practice of Pharmacy, 19th edn. Easton: Mack Publishing Co, 1995; pp 101-102.
6. Scheinfeld N, Rosenberg JD, Weinberg JM: Levamisole in dermatology: a review. Am J Clin Dermatol 2004; 5: 97-104.
7. Hadden JW: T-cell adjuvants. Int J Immunopharmacol 1994; 16: 703-710.
8. Szeto C, Gillespie KM, Mathieson PW: Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance. Immunology 2000; 100: 217-224. (Pubitemid 30348868)
9. Kocabas CN, Sekerel BE, Firat PA, et al: Levamisole: might it be used in treatment and prevention of atopic diseases? J Asthma 2004; 41: 547-551.
10. H2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol 2002; 109: 694-700.
11. Confino-Cohen R, Goldberg A, Aharoni D, et al: Low stimulated IL-4 secretion in PBMC from patients with chronic idiopathic urticaria. Cytokine 2004; 27: 74-80. (Pubitemid 38881529)